Compound index

Growth Hormone Secretagogues & GHRH Analogs

Tesamorelin

FDA-approved for specific indicationsFDA-approved

Last reviewed: 2026-11-19

History

Theratechnologies developed tesamorelin; FDA approval began in 2010.

Key sources

Indication-specific regulatory sources and editorial screen checked November 19, 2026. This is not an exhaustive systematic review; consult current labels.

Related compounds

  • CJC-1295

    Same target family · A 29-amino-acid chain. · Early human trials

  • Examorelin

    Same scientific class · A 6-amino-acid chain. · Early human trials

  • Ipamorelin

    Same scientific class · A 5-amino-acid chain. · Early human trials

  • Modified GRF (1–29)

    Same target family · A 29-amino-acid chain. · Cell/lab studies only

  • Pralmorelin

    Same scientific class · A 6-amino-acid chain. · Early human trials

Related glossary terms